Nonhormonal Therapies for Menopausal Vasomotor Symptoms

JAMA. 2023 Oct 3;330(13):1278-1279. doi: 10.1001/jama.2023.15965.
No abstract available

Plain language summary

This JAMA Insights in the Women’s Health series describes the use of fezolinetant and neurokinin B antagonists as nonhormonal therapies for menopausal vasomotor symptoms.